Penicillin-Binding Protein 2 Is Essential for Expression of High-Level Vancomycin Resistance and Cell Wall Synthesis in Vancomycin- Resistant Staphylococcus aureus Carrying the Enterococcal vanA Gene Complex
Open Access
- 1 December 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (12) , 4566-4573
- https://doi.org/10.1128/aac.48.12.4566-4573.2004
Abstract
A combination of biochemical and genetic experiments were performed in order to better understand the mechanism of expression of high-level vancomycin resistance in Staphylococcus aureus. The transcription of pbp2 of the highly vancomycin- and oxacillin-resistant strain COLVA200 and its mutant derivative with inactivated mecA were put under the control of an inducible promoter, and the dependence of oxacillin and vancomycin resistance and cell wall composition on the concentration of the isopropyl-β-d-thiogalactopyranoside inducer was determined. The results indicate that mecA—the genetic determinant of oxacillin resistance—while essential for oxacillin resistance, is not involved with the expression of vancomycin resistance. Penicillin binding protein 2A, the protein product of mecA, appears to be unable to utilize the depsipeptide cell wall precursor produced in the vancomycin-resistant cells for transpeptidation. The key penicillin binding protein essential for vancomycin resistance and for the synthesis of the abnormally structured cell walls characteristic of vancomycin-resistant S. aureus (A. Severin, K. Tabei, F. Tenover, M. Chung, N. Clarke, and A. Tomasz, J. Biol. Chem. 279:3398-3407, 2004) is penicillin binding protein 2.Keywords
This publication has 23 references indexed in Scilit:
- High Level Oxacillin and Vancomycin Resistance and Altered Cell Wall Composition in Staphylococcus aureus Carrying the Staphylococcal mecA and the Enterococcal vanA Gene ComplexPublished by Elsevier ,2004
- Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureusScience, 2003
- Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance GeneNew England Journal of Medicine, 2003
- Structural basis for the β lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureusNature Structural & Molecular Biology, 2002
- Complementation of the Essential Peptidoglycan Transpeptidase Function of Penicillin-Binding Protein 2 (PBP2) by the Drug Resistance Protein PBP2A in Staphylococcus aureusJournal of Bacteriology, 2001
- Regulation of VanA- and VanB-Type Glycopeptide Resistance in EnterococciAntimicrobial Agents and Chemotherapy, 2001
- Characterization of Staphylococcus aureus Cell Wall Glycan Strands, Evidence for a New β-N-Acetylglucosaminidase ActivityPublished by Elsevier ,2000
- Massive Reduction in Methicillin Resistance by Transposon Inactivation of the Normal PBP2 in a Methicillin-Resistant Strain ofStaphylococcus aureusMicrobial Drug Resistance, 1997
- Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanABiochemistry, 1991
- MECHANISM OF BACITRACIN ACTION: A SPECIFIC LIPID‐PEPTIDE INTERACTION*Annals of the New York Academy of Sciences, 1974